RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS)

Clinical trials for RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS) explained in plain language.

Never miss a new study

Get alerted when new RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS) trials appear

Sign up with your email to follow new studies for RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot cell therapy aims to reset immune system in devastating brain diseases

Disease control Recruiting now

This early-stage study is testing a new, 'off-the-shelf' CAR-T cell therapy called RD06-05 in adults with severe, hard-to-treat neurological autoimmune diseases like multiple sclerosis and myasthenia gravis. The goal is to see if a single infusion of these engineered immune cells…

Matched conditions: RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS)

Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS)

Get alerted when new RELAPSING OR REFRACTORY MULTIPLE SCLEROSIS (MS) trials appear

One-Shot cell therapy aims to reset immune system in devastating brain diseases